Dr. Foluso Agboola will provide a brief background on the Institute for Clinical and Economic Review and describe the Value Assessment Framework using their review of esketamine for treatment-resistant depression as an example.
from NIMH News Feed https://ift.tt/9AaHF01
Monday, February 28, 2022
Director’s Innovation Speaker Series: Beyond FDA Approval: Assessing the Value of New Health Technologies
Director’s Innovation Speaker Series: Beyond FDA Approval: Assessing the Value of New Health Technologies
Reviewed by Unknown
on
2:04 PM
Rating: 5
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment